Rare diseases
Investigational molecules
Locations
Gaustadalleen 21, 0349 Oslo, Norway
Agiana Pharmaceuticals AS focuses its research efforts on advancing treatments for malignant neoplasms, with particular emphasis on addressing solid tumors. The company's therapeutic development program targets critical challenges in cancer progression and aims to provide novel interventions for patients with advanced disease states.
The sponsor's research portfolio demonstrates a commitment to exploring innovative approaches in cancer treatment, focusing on patient populations with significant unmet medical needs in the oncology therapeutic area.
Agiana Pharmaceuticals AS runs clinical trials in conditions such as Ventricular tachycardia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
NorwayIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
